In line, we recently measured a substantial reduction both of CRHBP mRNA and protein immunopositivity in ccRCC [7] thus raising the question whether epigenetic silencing of the gene could occur in tumors. The gene discussed is CRHBP; the disease is nonpapillary renal cell carcinoma.